Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer

This phase 1, open‐label, dose‐escalation study was conducted to determine the safety, tolerability, pharmacokinetics and preliminary efficacy of veliparib with carboplatin and weekly paclitaxel in Japanese women with newly diagnosed, advanced ovarian cancer. Patients received veliparib at 100 or 15...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Sci
Main Authors: Nishio, Shin, Takekuma, Munetaka, Takeuchi, Satoshi, Kawano, Kouichirou, Tsuda, Naotake, Tasaki, Kazuto, Takahashi, Nobutaka, Abe, Masakazu, Tanaka, Aki, Nagasawa, Takayuki, Shoji, Tadahiro, Xiong, Hao, Nuthalapati, Silpa, Leahy, Terri, Hashiba, Hideyuki, Kiriyama, Tsukasa, Komarnitsky, Philip, Hirashima, Yasuyuki, Ushijima, Kimio
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2017
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665762/
https://ncbi.nlm.nih.gov/pubmed/28837250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13381
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍